Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.8%

4 terminated/withdrawn out of 105 trials

Success Rate

93.2%

+6.7% vs industry average

Late-Stage Pipeline

13%

14 trials in Phase 3/4

Results Transparency

13%

7 of 55 completed trials have results

Key Signals

18 recruiting7 with results

Enrollment Performance

Analytics

N/A
51(60.7%)
Phase 2
15(17.9%)
Phase 3
9(10.7%)
Phase 4
5(6.0%)
Phase 1
4(4.8%)
84Total
N/A(51)
Phase 2(15)
Phase 3(9)
Phase 4(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (105)

Showing 20 of 105 trials
NCT05007795Not ApplicableNot Yet Recruiting

Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis

Role: collaborator

NCT04700579Recruiting

Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis

Role: lead

NCT04923958Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network

Role: collaborator

NCT05317247Recruiting

Cough Audio Classification as a TB Triage Test

Role: lead

NCT03730181Phase 1Completed

Tuberculosis Clinical Trials Consortium Study 35

Role: collaborator

NCT03851159Not ApplicableActive Not Recruiting

Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota

Role: lead

NCT05333679Not ApplicableCompleted

Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)

Role: collaborator

NCT06635642Not ApplicableWithdrawn

Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)

Role: collaborator

NCT03601806Phase 2Completed

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Role: collaborator

NCT06593080Not ApplicableRecruiting

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Role: collaborator

NCT04752592Not ApplicableCompleted

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

Role: collaborator

NCT07463040Phase 3Not Yet Recruiting

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Role: collaborator

NCT05556746Phase 2Active Not Recruiting

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

Role: collaborator

NCT06965491Not ApplicableCompleted

The Effects of Exogenous Ketosis on Ultra-endurance Recovery and Performance

Role: collaborator

NCT05553236Not ApplicableRecruiting

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Role: collaborator

NCT02750202Phase 3Completed

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Role: collaborator

NCT03517878Completed

Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South Africa

Role: collaborator

NCT06152003Not ApplicableNot Yet Recruiting

Intervention Development for Syndemics Among PWH in SA

Role: collaborator

NCT04308928Completed

Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis

Role: lead

NCT05914324Not ApplicableRecruiting

Outpatient Pediatric Pulse Oximeters in Africa

Role: collaborator